Related Experiment Video
Updated: Oct 9, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.2K
Conditional prediction of consecutive tumor evolution using cancer progression models: What genotype comes next?
Juan Diaz-Colunga1,2,3, Ramon Diaz-Uriarte1,2
1Department of Biochemistry, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Plos Computational Biology
|December 21, 2021
Summary
Cancer progression models (CPMs) can predict the next mutation in tumor evolution. Short-term predictions are more reliable than full evolutionary paths, especially when adapting methods to specific cancer genotype characteristics.
Area of Science:
- Oncology
- Computational Biology
- Evolutionary Genetics
Background:
- Accurate prediction of tumor progression is crucial for developing adaptive therapy and precision medicine strategies.
- Cancer progression models (CPMs) infer mutation accumulation dependencies from cross-sectional data, aiding in predicting tumor evolutionary paths.
- Current CPMs face limitations in predicting complete evolutionary trajectories due to violated assumptions and data limitations.
Purpose of the Study:
- To evaluate the efficacy of five distinct CPMs in predicting the immediate next mutation in tumor progression (i.e., "What genotype comes next?" from a genotype with n mutations to n+1).
- To assess the performance of CPMs for short-term tumor evolution predictions, which are more relevant for diagnostic and therapeutic applications.
- To investigate the influence of genotype and fitness landscape characteristics on the accuracy of CPM predictions.
Main Methods:
- Utilized simulated data to test five different Cancer Progression Models (CPMs).
- Focused on predicting the single next mutational step in tumor evolution.
- Applied selected CPMs to 25 real-world cancer datasets.
Main Results:
- CPMs can accurately predict short-term tumor evolution under specific genotype and fitness landscape conditions.
- Certain genotype characteristics significantly impact prediction accuracy more than global features.
- Application to real cancer data revealed challenges due to insufficient information for informed method selection.
Conclusions:
- Short-term mutation prediction using CPMs shows promise, but performance is highly dependent on specific biological contexts.
- Effective use of CPMs requires tailoring method selection to local genotype characteristics and establishing reliable performance metrics.
- Further research is needed to clarify CPM interpretation when core assumptions are not met in real cancer data.
More Related Videos
Related Concept Videos
02:07Tumor Progression
6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
01:21Cancer Survival Analysis
478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478
01:33Cancer-Critical Genes I: Proto-oncogenes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
02:43Mouse Models of Cancer Study
5.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K